الوصف

Study design and enrollment details for the Phase II polycentric trial of Lertal (Perilla extract, quercetin, vitamin D3) in preventing allergic rhinoconjunctivitis exacerbations in children are described.

Figure 1

Flowchart

Source Paper

A polycentric, randomized, parallel-group, study on Lertal®, a multicomponent nutraceutical, as preventive treatment in children with allergic rhinoconjunctivitis: phase II.

Italian journal of pediatrics (2019)

PMID: 31319883

DOI: 10.1186/s13052-019-0678-y

Cite This Figure

![Figure 1: Study design and enrollment details for the Phase II polycentric trial of Lertal (Perilla extract, quercetin, vitamin D3) in preventing allergic rhinoconjunctivitis exacerbations in children are described.]()

> Source: Gianluigi Marseglia et al. "A polycentric, randomized, parallel-group, study on Lertal®, a multicomponent nu." *Italian journal of pediatrics*, 2019. PMID: [31319883](https://pubmed.ncbi.nlm.nih.gov/31319883/)

<figure>
  <img src="" alt="Study design and enrollment details for the Phase II polycentric trial of Lertal (Perilla extract, quercetin, vitamin D3) in preventing allergic rhinoconjunctivitis exacerbations in children are described." />
  <figcaption>Figure 1. Study design and enrollment details for the Phase II polycentric trial of Lertal (Perilla extract, quercetin, vitamin D3) in preventing allergic rhinoconjunctivitis exacerbations in children are described.<br>  Source: Gianluigi Marseglia et al. "A polycentric, randomized, parallel-group, study on Lertal®, a multicomponent nu." <em>Italian journal of pediatrics</em>, 2019. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31319883/">31319883</a></figcaption>
</figure>

أدلة ذات صلة

Quercetin لـ Allergic Rhinitis

التقييم C · 5 دراسات